Cleveland clinic reveal new therapeutic methods

More than 20 key physicians from Cleveland Clinic, Ohio, have discussed at Arab Health Congress 2015, the latest research conducted by the medical teams at the Cleveland Clinic, Ohio, in the United States, to reach diagnostic and therapeutic sophisticated methods in various medical specialties to reduce suffering of patients and complications associated with various medical conditions.
Dr. Rafi Avitsian, anaesthesiologist at Cleveland Clinic, Ohio, and speaker at the Anaesthesiology Conference during Arab Health, spoke about aesthetic considerations in the treatment of acute stroke. "Acute Stroke is a devastating disease which can cause patient's death or disability for the rest of their life. It is only a few hours of golden time that if treated appropriately there is still chance to return to normal life." He added that anaesthesiologists have critical role in preparing and maintaining stability and safety in patients during the short time of intravascular treatment of patients with acute ischemic stroke. "The Cleveland Clinic Stroke team and Neuro anaesthesiologists are currently investigating the best aesthetic method (general vs. sedation) for these patients. Cleveland Clinic stroke team, endovascular neurosurgeons, neuro radiologists and Neuro anaesthesiologists have implemented a rapid response method for receiving and treating these patients in the safest and fastest manner." Dr. Thomas Frazeir says, director of Cleveland Clinic Children's Centre for Autism, said, "The new DSM-5 criteria for autism spectrum disorder allows for accurate identification of both high and low functioning cases. At Cleveland Clinic Children's I Ohio, we are developing remote eye gaze tracking to social information as an objective market of autism. Our translational research programme is also focusing on understanding a genetic sub-group of autism, PTEN-ASD, in the hopes of identifying new treatments that compensate for mutations in the PTEN gene." In one of his presentations, Dr. Matthew Kroh, director of Surgical Endoscopy at Cleveland Clinic, Ohio, showcased: POEM procedure: a new, less invasive procedure for treatment of achalasia. Endoluminal treatment for metabolic diseases- new, non-surgical, less invasive treatments for diabetes and other obesity related diseases. Surgeons and flexible endoscopy- new applications of flexible endoscopy and robotics for treatment of surgical diseases performed by surgeons. Complex abdominal wall reconstruction examining new surgical techniques for repair of hernias.
Dr. Edmund Sabanegh, chairman of Urology Department at Cleveland Clinic spoke about the developments of fertility testing where traditional fertility tests such as semen analysis offer limited value for diagnosing cause of infertility. New tests which assess sperm function including DNA fragmentation tests which examine the genetics of sperm may allow us to better diagnose and treat male infertility.
In his second talk on focal treatments to improve fertility, he said, "there is a variety of effective treatments for male infertility. However, testosterone supplements are commonly prescribed for male infertility. They are in fact hazardous for fertility and should be avoided in men trying to cause a pregnancy." Dr. Eric Klein, chairman of Urology and Kidney Institute at Cleveland Clinic, focused on the emerging field of "precision medicine" in prostate cancer, highlighting how new biomarkers can help individualise diagnostic and treatment approaches to prostate cancer, including markers that are more specific than PSA for finding cancer, markers which help determine if a diagnosed cancer needs to be treated, biomarkers that can indicate the need for radiation therapy after surgery, and markers that can help determine which drugs should be used for the treatment of advanced disease.
Dr. Naim Alkhouri, director of paediatric metabolic liver disease clinic discussed with attendee the oral new hepatitis C medication that can cure high number of patients without using painful interferon injections. He also presented a talk on fatty liver disease that mainly affects obese patients and can lead to liver cirrhosis. Treating hepatitis B in children and pregnant women were amongst some of the hot topics too.
Dr. George Thomas, Cleveland Clinic nephrologist and hypertension specialist and activity director of the 1st Hypertension Conference during Arab Health Congress, said, "Cleveland Clinic is proud to support the 1st Gulf Hypertension conference, organised as part of the Arab health congress. The topics covered by international and regional speakers included diagnosis and management strategies for hypertension, as well as a discussion on new developments in hypertension." He added that one of the key issues raised during the talks and discussion was the possible development of a hypertension society focusing on the unique needs of the population in the Middle East, which would provide impetus for research and shape public health policy in the region to tackle hypertension and its related complications.
Source: WAM